Epinephrine Market Report – Research, Industry Analysis Reports and Market Demands

Epinephrine Market to 2027 - Global Analysis and Forecasts By Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); and Geography

Request for Sample of this report

Buy now

Table of Content

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Epinephrine Market - By Product Type
- 1.3.2 Global Epinephrine Market - By Application
- 1.3.3 Global Epinephrine Market - By Distribution Channel
- 1.3.4 Global Epinephrine Market - By Geography

2. Epinephrine Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Epinephrine- Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Epinephrine Market in Europe: PEST Analysis
- 4.2.3 Epinephrine Market in APAC: PEST Analysis
- 4.2.4 Middle East & Africa - PEST Analysis
- 4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion

5. Epinephrine Market - Key Dynamics

5.1 Drivers
- 5.1.1 Increasing Number of Anaphylaxis Cases
- 5.1.2 Introduction of generic version of epinephrine
5.2 Restraints
- 5.2.1 Lack of Availability of Epinephrine Auto-Injectors and Their Low-Cost Alternatives
5.3 Opportunities
- 5.3.1 Growing Pipeline of Epinephrine
5.4 Trends
- 5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis

6. Epinephrine Market - Global Analysis

6.1 Global Epinephrine Market Revenue Forecast And Analysis
6.2 Global Epinephrine Market, By Geography - Forecast And Analysis
6.3 Market Share of Key Players
- 6.3.1 Mylan N.V.
- 6.3.2 Teva Pharmaceutical Industries Ltd.

7. Epinephrine Market Analysis and Forecast - By Product Type

7.1 Overview
7.2 Epinephrine Market, by Product Type, 2019 and 2027 (%)
7.3 Prefilled Syringes
- 7.3.1 Overview
- 7.3.2 Epinephrine Market for Prefilled Syringes, Revenue and Forecast to 2027 (US$ Mn)
7.4 Auto-Injectors
- 7.4.1 Overview
- 7.4.2 Epinephrine Market for Auto-Injectors , Revenue and Forecast to 2027 (US$ Mn)
7.5 Ampoules and Vials
- 7.5.1 Overview
- 7.5.2 Epinephrine Market for Ampoules and Vials, Revenue and Forecast to 2027 (US$ Mn)

8. Epinephrine Market Analysis and Forecast - By Application

8.1 Overview
8.2 Epinephrine Market, by Application, 2019 and 2027 (%)
8.3 Anaphylaxis
- 8.3.1 Overview
- 8.3.2 Epinephrine Market for Anaphylaxis, Revenue and Forecast to 2027 (US$ Mn)
8.4 Superficial Bleeding
- 8.4.1 Overview
- 8.4.2 Epinephrine Market for Superficial Bleeding, Revenue and Forecast to 2027 (US$ Mn)
8.5 Respiratory Disorders
- 8.5.1 Overview
- 8.5.2 Epinephrine Market for Respiratory Disorders, Revenue and Forecast to 2027 (US$ Mn)
8.6 Cardiac Arrest
- 8.6.1 Overview
- 8.6.2 Epinephrine Market for Cardiac Arrest, Revenue and Forecast to 2027 (US$ Mn)

9. Epinephrine Market Analysis and Forecast - By Distribution Channel

9.1 Overview
9.2 Epinephrine Market, by Distribution Channel, 2019 and 2027 (%)
9.3 Retail Pharmacies
- 9.3.1 Overview
- 9.3.2 Epinephrine Market for Retail Pharmacies, Revenue and Forecast to 2027 (US$ Mn)
9.4 Hospital Pharmacies
- 9.4.1 Overview
- 9.4.2 Epinephrine Market for Hospital Pharmacies, Revenue and Forecast to 2027 (US$ Mn)
9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Epinephrine Market for Online Pharmacies, Revenue and Forecast to 2027 (US$ Mn)

10. Epinephrine Market - Geographic Analysis

Description

The global epinephrine market is expected to reach US$ 4,207.88 Mn in 2027 from US$ 2,247.87 Mn in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027.

The growth of the epinephrine market is estimated to due to driving factors such as increasing anaphylaxis cases and introduction of generic version of epinephrine are expected to boost the market growth over the years. On the other hand the market is expected to have restricted growth due to lack of availability of epinephrine auto injectors and their low-cost alternatives.

Epinephrine is the most effective treatment for anaphylaxis; however, various studies indicate underutilization of this drug due to high cost, lack of availability, unawareness regarding usage procedure and anaphylactic onset, etc. With steep price hike over the past decade, the lack of affordable alternatives have caused trouble for the patient to access this drug. EpiPen is an injection device that dispenses epinephrine, and people with severe allergies have been relying on it in case of life-threatening allergic reactions. Epinephrine alone is a generic drug, but the EpiPen is a drug-device combination product, which makes it difficult to replicate and get FDA approval for competitors. Therefore, there are limited number of players in this space. Moreover, the demand for epinephrine has been on the rise with limited product supply. As per the Pew Charitable Trusts, demand for epinephrine auto-injectors has increased in the last few years, and the number of EpiPen prescriptions in the US grew from ~2.5 million in 2011 to 3.5 million in 2015. The growth can be attributed to the high demand from schools.

Mylan has been a dominant player in the epinephrine auto-injector market since long. However, in 2018, Teva Pharmaceutical received the generic version FDA approval for its epinephrine auto-injector. This approval is the first generic version of the most widely prescribed epinephrine auto-injector in the US. It is expected to advance access to lower cost, safe, and effective generic alternatives in the future. Patients usually don't have enough choice in medication for such life-threatening conditions; however, as more generics enter the market, providers and patients have more choices.

The epinephrine market is segmented into type, application and distribution channel. Based on type the market is segmented as prefilled syringes, auto-injectors, ampoules and vials. On the basis of application the market is divided into anaphylaxis, superficial bleeding, respiratory disorders, and cardiac arrest. And based on the distribution channel the market is categorized as retail pharmacies, hospital pharmacies, and online pharmacies

Some of the important primary and secondary sources included in the report are, Food and Drug Administration (FDA), World Health Organization (WHO), Brazilian Society of Allergy and Immunology, Australasian Society of Clinical Immunology and Allergy, European Medicines Agency, Dubai Health Authority, and others.